Company intelligence / Profile preview
Novosibkhimpharm
- Ownership
- Private
- Employees
- ~700
- Development stage
- Other
Overview
Novosibkhimpharm is a major Russian pharmaceutical manufacturer based in Novosibirsk, specializing in the production of generic medicines. Founded in 1941 during World War II, the company has evolved into a key production site for essential drugs, particularly in injectable forms. It operates as a subsidiary of the Binnopharm Group, one of the largest pharmaceutical holdings in Russia. The company's portfolio includes over 100 products across various therapeutic areas such as pain management, cardiology, and neurology. Novosibkhimpharm is recognized for its large-scale manufacturing capabilities, including high-volume production of ampoules and tablets under GMP standards.
- Therapeutic areas
- ImmunologyOtherCardiovascularNeurologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Novosibkhimpharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novosibkhimpharm.